FDA and EMA agree to intensify collaboration during COVID-19 pandemic
June 23, 2020Manufacturing and Production COVID-19, coronavirus
Senior officials from the US Food and Drug Administration and the European Medicines Agency have pledged to continue working closely …
How is COVID-19 impacting the rare disease community?
June 22, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, cambridge rare disease network, pharma, rare disease
The COVID-19 pandemic has altered the life of just about everyone, especially patients in receiving continued treatment and care. But …
Sanofi’s Dupixent scores Chinese approval in moderate to severe atopic dermatitis
June 22, 2020Sales and Marketing China, Dupixent, Sanofi, atopic dermatitis, pharma
China’s National Medical Products Administration (NMPA) has moved to approve a 300mg pre-filled pen formulation of Sanofi and Regeneron’s Dupixent …
New UK consortium established to monitor COVID-19 vaccine efficacy once they hit market
June 22, 2020Manufacturing and Production, Sales and Marketing COVID-19, DSRU, MEMO Research, Vaccine, coronavirus, pharma
The UK’s Drug Safety Research Unit (DSRU) and the University of Dundee’s Medicines Monitoring Unit (MEMO Research) have come together …
SAGE group warns it is not safe to relax social distancing rules across Britain
June 22, 2020Sales and Marketing COVID-19, coronavirus, pandemic
The Independent SAGE group has warned that it is not safe to relax social distancing rules for indoor settings, after …
NIH halts hydroxychloroquine trial after no benefit found in COVID-19 patients
June 22, 2020Sales and Marketing COVID-19, chloroquine, hydroxychloroquine, pandemic
The National Institutes of Health (NIH) have suspended clinical trials of hydroxychloroquine after the drug was found to have no …
Germany’s infection rate rapidly rises as world sees its largest daily increase in COVID-19 cases
June 22, 2020Sales and Marketing COVID-19, coronavirus, pandemic
Germany’s coronavirus R number has drastically increased while the world faced its largest increase in cases since the pandemic began. …
EU reportedly in talks with J&J to secure doses of its COVID-19 vaccine
June 19, 2020Medical Communications, Research and Development, Sales and Marketing COVID-19, EU, Europe, J&J, JJ, Vaccine
It has been reported that the European Union is currently negotiating a deal with pharma giant Johnson & Johnson to …
Florida approve plan to release 750 million genetically modified mosquitoes to stop the spread of disease
June 19, 2020Medical Communications AIDS, HIV, mosquitoes
Florida state regulators have gained approval to release 750 million genetically modified mosquitoes across the state to reduce the spread …
FDA approves Crysvita for treating tumour-induced osteomalacia
June 19, 2020Medical Communications FDA, FDA approvals
The FDA has approved Crysvita (burosumabtwza) injection to treat patients over two years old with tumour-induced osteomalacia (TIO). This is …
Top Ten most popular articles on Pharmafile.com this week
June 19, 2020Medical Communications COVID-19, coronavirus, top 10
The news this week centres around COVID-19 vaccines, as Moderna is to start testing 30,000 people with its vaccine beginning …
Study launched to assess if asthma treatment ciclesonide can treat COVID-19
June 18, 2020Business Services COVID-19, asthma, corona, coronavirus
Researchers at the University of Buffalo have launched a study to see if the steroid treatment ciclesonide could be effective …
Experts warn UK government that unnecessary deaths will occur if lockdown is lifted before contact tracing system is implemented
June 18, 2020Business Services COVID, COVID-19, coronavirus
The British government is risking many unnecessary deaths if it lifts the lockdown before an effective contact tracing system is …
Roche’s rheumatoid arthritis drug Actemra shows no benefit in COVID-19 pneumonia
June 18, 2020Research and Development Actemra, COVID-19, Roche, coronavirus
Hope is waning around the efficacy of Roche’s Actemra (tocilizumab) following the release of results from an Italian study focusing …
US Strategic National Stockpile now has 66 million hydroxychloroquine pills that cannot be used for coronavirus
June 18, 2020Business Services COVID-19, chloroquine, coronavirus, hydroxychloroquine
The US is now sitting on a pile of 66 million anti-malaria pills, hydroxychloroquine and chloroquine, after they were removed …
FDA approval for Jazz and PharmaMar’s Zepzelca in metastatic small cell lung cancer
June 17, 2020Manufacturing and Production, Research and Development, Sales and Marketing Cancer, FDA, PharmaMar, Zepzelca, jazz pharma, lung cancer
The FDA has awarded approval to Jazz Pharma and PharmaMar for Zepzelca (lurbinectedin) as a treatment for metastatic small cell …
New data from diabetes prevention programme shows a reduction of type 2 diabetes
June 17, 2020Research and Development diabetes, type 2 diabetes
The Diabetes Prevention Program Outcomes Study (DPPOS) of 2,000 people showed a significant reduction in the participants’ risk of developing …
Repurposed corticosteroid dexamethasone shown to reduce mortality in COVID-19 patients needing respiratory support
June 17, 2020Research and Development COVID-19, University of Oxford, coronavirus, dexamethasone
The University of Oxford has unveiled exciting new data in the treatment of the novel coronavirus, with a randomised clinical …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
